Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer

被引:11
|
作者
Yu, Chunying [1 ]
Dou, Ting [1 ]
Liu, Yun [1 ]
Liu, Ruirong [1 ]
机构
[1] Third Peoples Hosp Qingdao, Dept Ultrason Med, 29 Yongping Rd, Qingdao 266041, Shandong, Peoples R China
关键词
ovarian cancer; color doppler ultrasound; transvaginal; tumor markers; serology; combined examination; DOPPLER SONOGRAPHY; OSTEOPONTIN; STAGE; DISCRIMINATION; ULTRASOUND; CA125;
D O I
10.3892/ol.2020.11705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical application value was investigated of transvaginal color Doppler ultrasound (TV-CDS) combined with serum tumor markers carbohydrate antigen 125 (CA125), vascular endothelial growth factor (VEGF) and osteopontin (OPN) in the diagnosis of ovarian cancer (OC). One hundred and six patients with OC [malignant tumor group (MTG)] and fifty patients with benign ovarian diseases [benign control group (BCG)] were selected. Both groups of patients underwent TV-CDS examination. The lesion morphology and internal structure were observed, and the tumor blood flow signal, resistance index (RI) and pulsability index (PI) under ultrasound were determined. Serum CA125 was detected by electrochemiluminescence, and VEGF and OPN levels were detected by enzyme-linked immunosorbent assay. The incidence of irregular lesion morphology, unclear boundary, uneven internal echo, microcalcification and side-acoustic images in OC group (OCG) was significantly higher than that in BCG (P<0.01). As for blood flow grading, most patients in the MTG were in grade II and III, while most patients in the BCG were in grade 0. Compared with BCG, the flow RI and PI in the OCG were significantly reduced (P<0.01). The levels of serum CA125, VEGF and OPN in OCG were significantly higher than those in BCG. The expression levels of serum CA125, VEGF and OPN in OC patients with clinical high stage (stage III and IV), poorly differentiated, ascites, recurrence and metastasis were significantly higher than those in patients with clinical low stage (stage I and II), well differentiated, no ascites and no recurrence and metastasis (P<0.05). With the disappearance of the tumor or the decrease of tumor load, the serum marker levels after treatment were significantly lower than that before treatment (P<0.05). The sensitivity and accuracy of the combined examination in the diagnosis of OC were obviously improved compared with the single and partial combined examinations (P<0.05). In conclusion, combined examination can significantly improve the sensitivity and accuracy of OC, which is conducive to early diagnosis and clinical intervention of OC.
引用
收藏
页码:2028 / 2034
页数:7
相关论文
共 50 条
  • [1] Clinical Significance of Combined Detection of Serum Tumor Markers in Diagnosis of Patients with Ovarian Cancer
    Bian, Jing
    Li, Bo
    Kou, Xian-Juan
    Liu, Tian-Zhou
    Ming, Liang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6241 - 6243
  • [2] Evaluation of clinical value of combined tumor markers detection in diagnosis of lung cancer
    Zhang, Guangming
    Deng, Shouzhen
    Wang, Yun
    Xu, Lianqin
    He, Wanting
    Gao, Quan
    Lin, Xiangtong
    He Jishu/Nuclear Techniques, 2002, 25 (05):
  • [3] Serum tumor markers for screening and early diagnosis of ovarian cancer
    Olaru, Octavian Gabriel J.
    Pena, Catalina Monica C.
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2013, 21 (04): : 465 - 472
  • [4] Serum tumor markers in breast cancer: Are they of clinical value?
    Duffy, MJ
    CLINICAL CHEMISTRY, 2006, 52 (03) : 345 - 351
  • [5] Clinical significance of combined detection of multiple serum tumor markers in the diagnosis of breast cancer
    Xu, Hong
    Sheng, Qiang
    Jiang, Ting
    Wei, Zhen
    Li, Shan
    Fang, Feng
    Zou, Liyong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 295 - 295
  • [6] CLINICAL VALUE OF SERUM TUMOR SUPPLIED GROUP OF FACTOR IN DIAGNOSIS OF EPITHELIAL OVARIAN CANCER
    程琪辉
    张喜平
    曾小澜
    Chinese Journal of Cancer Research, 2003, (03) : 79 - 81
  • [7] Clinical value of color Doppler ultrasound combined with serum tumor markers for the diagnosis of medullary thyroid carcinoma
    Yang, Xue
    Xu, Jinjuan
    Sun, Jilan
    Yin, Lizhi
    Guo, Rui
    Yan, Zhimei
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [8] CLINICAL VALUE OF COMBINED TESTS FOR TUMOR MARKERS FOR GASTRIC CANCER
    Xu, M. X.
    Cui, H. J.
    Yao, T. L.
    Gui, Y. F.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (02): : 263 - 268
  • [9] The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer
    Wu, Heming
    Wang, Qiuming
    Liu, Qinghua
    Zhang, Qunji
    Huang, Qingyan
    Yu, Zhikang
    CLINICAL LABORATORY, 2020, 66 (03) : 269 - 276
  • [10] The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
    Cheng, Xinyu
    Xia, Jianguo
    Xu, Qi
    Gui, Huawei
    OPEN MEDICINE, 2023, 18 (01):